NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT) for Failing to Meet Market Capitalization Standard
ByAinvest
Tuesday, Mar 3, 2026 4:04 pm ET1min read
RBOT--
The New York Stock Exchange (NYSE) has announced that it will commence delisting proceedings against Vicarious Surgical Inc. (RBOT) due to the company's failure to meet the NYSE's continued listing standard of maintaining an average global market capitalization of at least $15,000,000 over a consecutive 30 trading day period. Trading in RBOT's Class A common stock has been suspended immediately. The company has the right to a review by the NYSE's Board of Directors and can appeal the decision. The NYSE will apply to the Securities and Exchange Commission to delist RBOT's stock upon completion of all applicable procedures.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet